SCHEDULE 13D

Company

REVELATION BIOSCIENCES, INC.

Filed

February 15, 2022

Accession Number

0001213900-22-007741

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →